Thus, the finding that ZEB1 is regulated by miR551b has a huge potential impact on research on the EMT and cancer metastasis and suggested that miR551b is a good therapeutic alternative for inhibiting the EMT and tumor progression in CRC. The gene discussed is ZEB1; the disease is colorectal carcinoma.